Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Melanoma/Skin Cancer
Case Presentation: International Focus on the Management of Acral Lentiginous Melanoma
Melanoma/Skin Cancer
Read More ›
Commercial Availability of Anti–PD-1 Antibodies in Melanoma: A Benchmark of Success
By
Brianna W. Hoffner, MS, RN, ANP-BC, AOCNP
Melanoma/Skin Cancer
Read More ›
New Drugs and Clinical Trial Data: Updates in Cutaneous Malignancies
Melanoma/Skin Cancer
Read More ›
Targeted Agents, Immunotherapy, and Other Treatments Are Emerging for Cutaneous Malignancies
Melanoma/Skin Cancer
Read More ›
Combo of BRAF and MEK Inhibitors Improves Survival in Advanced Melanoma
By
Grant McArthur, MD, PhD
Melanoma/Skin Cancer
Read More ›
RAS and Colon Cancer: What You’re Missing
By
Sonia L. Ali, MD
Melanoma/Skin Cancer
Read More ›
Oncolytic Viruses for the Treatment of Advanced Melanoma
By
Beverly E Barton, PhD
Melanoma/Skin Cancer
Read More ›
Potential New Approach to Treatment of Melanoma
Melanoma/Skin Cancer
Read More ›
New Melanoma Guideline Adds BRAF Inhibitor, MEK Inhibitor to First-Line Systemic Therapy Options
By
John A. Thompson, MD
Melanoma/Skin Cancer
Read More ›
The New Therapeutic Paradigm for Personalized Therapy of Melanoma
By
Sanjiv S. Agarwala, MD
Melanoma/Skin Cancer
Read More ›
Page 2 of 3
1
2
3